Elevation of Platelet and Monocyte Activity Markers of Atherosclerosis in Haemodialysis Patients Compared to Peritoneal Dialysis Patients

Table 2

Medication in use at baseline.

Medication	HD patients	HD patients (%)	PD patients	PD patients (%)	value
ASA	5	12.2	1	10	1
Oral anticoagulants	9	21.95	1	10	0.664
Beta blocker	22	53.66	5	50	1
Statins	4	9.76	4	40	0.038
ACE-inhibitor/AT(1) antagonist	20	48.78	6	60	0.727

ASA = acetylsalicylic acid; ACE inhibitor = angiotensin-converting-enzyme inhibitor; AT (1) antagonist = angiotensin (1) antagonist.